Maitham Moslim MD DABS FACS FSSO

#DCRJournal Rectal Cancer Watch-and-Wait Management: Experience of 545 Patients From the US Rectal Cancer Research Group | bit.ly/42saxKI

KEYNOTE-937 @ #ASCOGI2026: Adjuvant pembrolizumab did not improve recurrence-free or overall survival after curative-intent therapy for HCC and had higher ≥G3 AEs. No change to standard of care. #HCC #LiverCancer oncodaily.com/opinion/keynot…

Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis academic.oup.com/bjs/article/11…

@OncBrothers @rutikamehtaMD @OncUpdates @gotoPER @MDmanishshah @ShrutiPatelMD @GIMedOnc @YJanjigianMD @RoswellPark @Sarbaji85064063 @GIcancerDoc @WCM_MeyerCancer Destiny Gastric 06 and Zani trial will be interesting down the lane x.com/ArndtVogel/sta…

In hemodynamically stable patients with delayed post-pancreaticoduodenectomy hemorrhage, angiography can be safely attempted as an initial management strategy. journals.lww.com/annalsofsurger…

Defining Biological Borderline Resectable Non-functioning... : Annals of Surgery journals.lww.com/annalsofsurger…

Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre phase II single-arm trial academic.oup.com/bjs/article/11…

Featured: Technical Aspects of Patch Reconstruction during Open and Robotic #Pancreatoduodenectomy with Venous Resection: Preserving Venous Axis and Collaterals without Sacrificing Radicality @prof_cillo rdcu.be/eTFQA @jhatjhmi1 @SyedAAhmad5 @SocSurgOnc

No-Cut Trial sciencedirect.com/science/articl…

FDA Approval for durvalumab combined with FLOT in #GastricCancer Based on MATTEHORN Source: AstraZeneca buff.ly/FSY8lTC Durvalumab combined with standard FLOT chemotherapy has received US approval for treating adults with resectable, early to locally advanced gastric and gastroesophageal junction cancers, based on the MATTERHORN Phase III trial, which showed a 29% reduction in the risk of disease progression, recurrence, or death and a 22% reduction in the risk of death compared with chemotherapy alone. The regimen involves neoadjuvant Durvalumab plus chemotherapy before surgery, followed by adjuvant combination therapy and then Imfinzi monotherapy. This FDA Priority Review approval was supported by event-free and overall survival data published in The New England Journal of Medicine. @pashtoonkasi @CathyEngMD @marklewismd @AndresC27622123 @manjuggm @stacy_hurt @ARosen380 @KoheiShitara @GillSharlene @BenWestphalen @NiuSanford #OncoAlertAF @nataliagandur @acampsmalea @BRicciutiMD @HHorinouchi @FadiHaddad_MD @Abdallah81MD @FernandoOnco @ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @UOzkerim @DrRishabhOnco @Onco_Cifu88

Intraoperative Carcinoid Crisis in NET Operations – Eluding Dogma with Current Understanding - Surgical Oncology Insight surgoncinsight.org/article/S2950-…

Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study - The Lancet Oncology thelancet.com/journals/lanon…

Durvalumab + FLOT—>✂️—>Durva now @FDAOncology ✅ for resectable GEJ/Gastric Ca based off #MATTERHORN study. - ⭐️ Improved OS in all comers (HR: 0.78) - Rate of✂️, # of FLOT, and AEs (Gr 3 & 4: 71%) similar in both arms. #OncTwitter @OncoAlert @OncUpdates @YJanjigianMD 👏👏

New data show radiotherapy can induce amphiregulin, reprogram myeloid cells, and support distant tumour growth. Understanding this may help us design better treatment paths for patients. @Nature @OncoAlert nature.com/articles/s4158…

Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study - The Lancet Oncology thelancet.com/journals/lanon…

Serum 5-Hydroxyindoleacetic Acid Measurements for the Diagnosis and Follow-up of Carcinoid Syndrome academic.oup.com/jcem/article/1…

Hepatectomy for oligometastatic liver disease in oesophageal adenocarcinoma: The METHEOR study - European Journal of Surgical Oncology ejso.com/article/S0748-…

Very proud and happy to share that our work on neoadjuvant IO in pMMR colon cancers has been published online in @Nature after presentation @myESMO #ESMO25. Preview: rdcu.be/eLTN1 Read on how genomic instability, P53mt and proliferation may aid in predicting responses.

The #OncoAlertTopTweet 🚨 Day FOUR #ESMO25 Post from @MyriamChalabi 🇳🇱 Just Published on nature: neoadjuvant IO in pMMR colon cancers Preview 👉 nature.com/articles/s4158… @nataliagandur @HHorinouchi @FernandoOnco @ElisaAgostinett @to_be_elizabeth @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @UOzkerim @DrRishabhOnco @DrSGraff @bavilima @DrChoueiri, @PGrivasMDPhD @neerajaiims, @tompowles1, @cdanicas @weoncologists @matteolambe @Icro_Meattini @aftimosp @TiansterZhang @stolaney1